Pages that link to "Q76741543"
Jump to navigation
Jump to search
The following pages link to Annemieke Geluk (Q76741543):
Displaying 50 items.
- Innovative Strategies to Identify M. tuberculosis Antigens and Epitopes Using Genome-Wide Analyses (Q27027110) (← links)
- Interferon-gamma production in response to M. tuberculosis antigens in TB patients in Indonesia (Q30976227) (← links)
- Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity (Q33535876) (← links)
- Field-evaluation of a new lateral flow assay for detection of cellular and humoral immunity against Mycobacterium leprae. (Q33583641) (← links)
- Clonal analysis of the T-cell response to in vivo expressed Mycobacterium tuberculosis protein Rv2034, using a CD154 expression based T-cell cloning method (Q33721633) (← links)
- Postgenomic approach to identify novel Mycobacterium leprae antigens with potential to improve immunodiagnosis of infection (Q34034065) (← links)
- Pathogen-specific epitopes as epidemiological tools for defining the magnitude of Mycobacterium leprae transmission in areas endemic for leprosy (Q34251374) (← links)
- T-cell responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 in Brazilian tuberculosis patients (Q34257293) (← links)
- Differential dermal expression of CCL17 and CCL18 in tuberculoid and lepromatous leprosy. (Q34549608) (← links)
- Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy. (Q34738690) (← links)
- The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: a cluster randomized controlled trial (MALTALEP study). (Q35006898) (← links)
- Identification of human T-cell responses to Mycobacterium tuberculosis resuscitation-promoting factors in long-term latently infected individuals (Q35066262) (← links)
- T-cell regulation in lepromatous leprosy (Q35145444) (← links)
- Lateral flow assay for simultaneous detection of cellular- and humoral immune responses. (Q35226256) (← links)
- Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. (Q35808883) (← links)
- Longitudinal immune profiles in type 1 leprosy reactions in Bangladesh, Brazil, Ethiopia and Nepal (Q35825015) (← links)
- Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination (Q35913675) (← links)
- Leprosy Diagnostic Test Development As a Prerequisite Towards Elimination: Requirements from the User's Perspective (Q35920727) (← links)
- New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy (Q35936136) (← links)
- HLA and leprosy in the pre and postgenomic eras (Q36489692) (← links)
- Field-Friendly Test for Monitoring Multiple Immune Response Markers during Onset and Treatment of Exacerbated Immunity in Leprosy. (Q36973964) (← links)
- From genome-based in silico predictions to ex vivo verification of leprosy diagnosis (Q37116579) (← links)
- Cell-type deconvolution with immune pathways identifies gene networks of host defense and immunopathology in leprosy (Q37277036) (← links)
- Quantitative lateral flow strip assays as User-Friendly Tools To Detect Biomarker Profiles For Leprosy (Q37294038) (← links)
- New Genome-Wide Algorithm Identifies Novel In-Vivo Expressed Mycobacterium Tuberculosis Antigens Inducing Human T-Cell Responses with Classical and Unconventional Cytokine Profiles (Q37445202) (← links)
- Postgenomic Mycobacterium leprae antigens for cellular and serological diagnosis of M. leprae exposure, infection and leprosy disease (Q37996033) (← links)
- Challenges in immunodiagnostic tests for leprosy (Q38093850) (← links)
- Biomarkers for leprosy: would you prefer T (cells)? (Q38112443) (← links)
- Longitudinal IP-10 Serum Levels Are Associated with the Course of Disease Activity and Remission in Patients with Rheumatoid Arthritis (Q38737488) (← links)
- Evaluation of cytokine responses against novel Mtb antigens as diagnostic markers for TB disease (Q38854202) (← links)
- Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB. (Q38854712) (← links)
- Multi-center evaluation of a user-friendly lateral flow assay to determine IP-10 and CCL4 levels in blood of TB and non-TB cases in Africa (Q38858066) (← links)
- Use of lateral flow assays to determine IP-10 and CCL4 levels in pleural effusions and whole blood for TB diagnosis (Q38918689) (← links)
- Functional characterization of ocular-derived human alphaherpesvirus cross-reactive CD4 T cells. (Q39016158) (← links)
- The in vivo expressed Mycobacterium tuberculosis (IVE-TB) antigen Rv2034 induces CD4⁺ T-cells that protect against pulmonary infection in HLA-DR transgenic mice and guinea pigs (Q39190589) (← links)
- Identification and characterization of the ESAT-6 homologue of Mycobacterium leprae and T-cell cross-reactivity with Mycobacterium tuberculosis (Q39654779) (← links)
- Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1. (Q40043123) (← links)
- Opening a Can of Worms: Leprosy Reactions and Complicit Soil-Transmitted Helminths (Q40061912) (← links)
- CRP: tell-tale biomarker or common denominator? (Q40077400) (← links)
- Field-friendly serological tests for determination of M. leprae-specific antibodies. (Q40085030) (← links)
- Differences in IgG responses against infection phase related Mycobacterium tuberculosis (Mtb) specific antigens in individuals exposed or not to Mtb correlate with control of TB infection and progression (Q40096151) (← links)
- Direct ex vivo detection of HLA-DR3-restricted cytomegalovirus- and Mycobacterium tuberculosis-specific CD4+ T cells (Q40339171) (← links)
- Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis (Q40706013) (← links)
- Exploratory urinary metabolomics of type 1 leprosy reactions (Q40774651) (← links)
- Peptides Derived from Mycobacterium leprae ML1601c Discriminate between Leprosy Patients and Healthy Endemic Controls (Q40867762) (← links)
- A BCR-ABL oncoprotein p210b2a2 fusion region sequence is recognized by HLA-DR2a restricted cytotoxic T lymphocytes and presented by HLA-DR matched cells transfected with an Ii(b2a2) construct (Q40939704) (← links)
- Enhancing sensitivity of detection of immune responses to Mycobacterium leprae peptides in whole-blood assays (Q41013632) (← links)
- Clinical manifestations of leprosy after BCG vaccination: an observational study in Bangladesh (Q41472120) (← links)
- T-cell recognition of the HspX protein of Mycobacterium tuberculosis correlates with latent M. tuberculosis infection but not with M. bovis BCG vaccination (Q41989008) (← links)
- Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection (Q41990768) (← links)